ESPR Gross Profit Growth

Esperion Therapeutics Inc · Gross Profit Growth

ESPR logo

ESPR Gross Profit Growth

Year-over-year change vs the same period a year earlier

Latest reported60.38%
ESPR TTM Gross Profit YoY % (-86.05% → 60.38%)
High-resolution chart · PNG

ESPR gross profit growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Esperion Therapeutics Inc Gross Profit Growth — Trailing twelve months (TTM)
Period endingGross Profit Growth
60.3764%
-1.4914%
-32.5102%
-27.3448%
-9.8591%
260.9194%
260.1372%
286.463%
280.0986%
50.6288%
51.5008%
45.0176%
-29.0665%
-24.4777%
-28.5802%
-28.3022%
-69.6144%
-71.473%
-65.6277%
-56.1865%
284.2969%
926.3479%
24.1004%
-14.3677%
-181.3849%
-309.8183%
153.782%
166.1012%
181.1682%
108.7979%
100%
100%
100%
100%
32.1429%
-86.0481%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.